Prominent protumoral cellular compartments of the tumor microenvironment in triple-negative breast cancer.
1/5 보강
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by the absence of estrogen, progesterone, and HER2 receptor expression.
APA
Sun S, Zhao P, et al. (2025). Prominent protumoral cellular compartments of the tumor microenvironment in triple-negative breast cancer.. Frontiers in cell and developmental biology, 13, 1668583. https://doi.org/10.3389/fcell.2025.1668583
MLA
Sun S, et al.. "Prominent protumoral cellular compartments of the tumor microenvironment in triple-negative breast cancer.." Frontiers in cell and developmental biology, vol. 13, 2025, pp. 1668583.
PMID
41584838 ↗
Abstract 한글 요약
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by the absence of estrogen, progesterone, and HER2 receptor expression. This malignancy is often associated with a poor prognosis, early recurrence, and limited treatment options. The tumor microenvironment (TME) in TNBC plays a pivotal role in tumor progression, immune evasion, and therapeutic resistance. In recent years, an increasing body of evidence has highlighted the critical interactions between cancer cells and the components within the TME, including immune cells and soluble components. These interactions influence not only the biological behavior of the tumor but also its response to treatment. Exploring the complex interplay between tumor cells and immune components continues to inform the development of more effective therapeutic approaches. In this study, we provide a synopsis of advancements regarding the TME in TNBC. In light of different cellular compartments, we delineate multiscale interplays within the stroma-tumor symbiosis and highlight their antitumor functions and promising targeting strategies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- The gut microbiome in colorectal anastomotic leakage: from mechanisms to precision.
- Association between ALK tyrosine kinase inhibitor and the risk of interstitial lung disease and pneumonitis in non-small cell lung cancer patients: a systematic review.
- A review on ethnobotanical uses, geographical distribution, phytochemistry, quality control and pharmacology of L. plants distributed in the northeastern region of China.
- PGM5 - AS1 regulates ferroptosis - Mediated gastric cancer cell behavior via ERK signaling pathway.
- Multicenter study provides radiomic and biological insights into neoadjuvant chemotherapy response and prognosis in luminal breast cancer.